Spots Global Cancer Trial Database for Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder Cancer
Official Title: Pilot Study of Celecoxib Combined With Gemcitabine and Cisplatin for Neoadjuvant Treatment of Localized, Muscle-Invasive Bladder Cancer
Study ID: NCT02885974
Conditions
Study Description
Brief Summary: The purpose of this study is to compare patient tumor tissue before and after treatment with chemotherapy plus celecoxib. Investigators will look at gene expression, to see what effect celecoxib may have on tumor cells.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Baylor Clinic, Houston, Texas, United States
Harris Health System - Smith Clinic, Houston, Texas, United States
Contact Details
Name: Aihua Edward Yen, MD
Affiliation: Baylor College of Medicine
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
